NYSE : AVTR
Avantor, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 16.68 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 11.30B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 10.88B |
| Enterprise Value | 14.10B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 677.62M |
| Shares Outstanding | 677.62M |
| Shares Change (YoY) | -0.49% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 101.90% |
| Float | 659.06M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 32.21 |
| Forward PE | 18.36 |
| PS Ratio | 1.64 |
| Forward PS | 1.61 |
| PB Ratio | 1.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.76 |
| P/OCF Ratio | 18.60 |
| PEG Ratio | 13.95 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 41.80 |
| EV / Sales | 2.12 |
| EV / EBITDA | 14.87 |
| EV / EBIT | 26.68 |
| EV / FCF | 32.09 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.89 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 3.66 |
| Debt / FCF | 8.39 |
| Interest Coverage | 2.49 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 5.91% |
| Return on Assets (ROA) | 2.83% |
| Return on Invested Capital (ROIC) | 5.85% |
| Return on Capital Employed (ROCE) | 5.15% |
| Weighted Average Cost of Capital (WACC) | 8.23% |
| Revenue Per Employee | $491,526 |
| Profits Per Employee | $24,978 |
| Employee Count | 13,500 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 5.50 |
Taxes
| Measure | Value |
|---|
| Income Tax | -21.70M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +38.60% |
| 50-Day Moving Average | 15.49 |
| 200-Day Moving Average | 11.19 |
| Relative Strength Index (RSI) | 49.10 |
| Average Volume (20 Days) | 10,723,354 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 34.65M |
| Short Previous Month | 51.37M |
| Short % of Shares Out | 5.11% |
| Short % of Float | 5.26% |
| Short Ratio (days to cover) | 4.07 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 6.64B |
| Gross Profit | 2.10B |
| Operating Income | 528.40M |
| Pretax Income | 315.50M |
| Net Income | 337.20M |
| EBITDA | 947.60M |
| EBIT | 528.40M |
| Earnings Per Share (EPS) | $0.50 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 464.30M |
| Total Debt | 3.68B |
| Net Cash | -3.22B |
| Net Cash Per Share | -$4.75 |
| Equity (Book Value) | 5.84B |
| Book Value Per Share | 8.61 |
| Working Capital | 1.22B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 584.70M |
| Capital Expenditures | -145.50M |
| Depreciation & Amortization | 419.20M |
| Net Borrowing | -135.70M |
| Free Cash Flow | 439.20M |
| FCF Per Share | $0.65 |
Margins
| Measure | Value |
|---|
| Gross Margin | 31.59% |
| Operating Margin | 7.96% |
| Pretax Margin | 4.75% |
| Profit Margin | 5.08% |
| EBITDA Margin | 14.28% |
| EBIT Margin | 7.96% |
| FCF Margin | 6.62% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.49% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.10% |
| FCF Yield | 4.04% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $17.35 |
| Price Target Difference | 8.10% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 2.73% |
| EPS Growth Forecast (3Y) | 2.40% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.86 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |